In contrast, IL-4 aids cancer-initiating cells (CICs) responsible for tumor initiation, propagation, and resistance to chemotherapy, to escape from T cell-mediated immunosurveillance through membrane-bound IL-4 in colorectal cancer patients. This evidence concerns the gene IL4 and neoplasm.